Novavax Inc (NVAX)

NASDAQ HEALTHCARE
$8.07 -1.82% RSI 39 Neutral Add Alert

Moving Averages

SMA 200
$8.04
Price near

Company Profile

Novavax, Inc., a biotechnology company, focuses on the discovery, development and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company is headquartered in Gaithersburg, Maryland.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$1.39B
P/E Ratio
3.26
EPS
$2.62
Beta
2.648
Dividend Yield
0.00%
52-Week High
$11.97
52-Week Low
$5.8

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 57.0
VRTX
Vertex Pharmaceuticals Inc
RSI 41.0
CRSP
CRISPR Therapeutics AG
RSI 50.0
MRNA
Moderna Inc
RSI 36.0
VKTX
Viking Therapeutics Inc
RSI 38.0
SRPT
Sarepta Therapeutics Inc
RSI 51.0

Data last updated: April 11, 2026 at 2:26 AM EDT

Track NVAX for free

Get e-mail RSI alerts when Novavax Inc enters oversold or overbought territory. Free forever.

Add Alert